Matches in Wikidata for { <http://www.wikidata.org/entity/Q83178347> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q83178347 description "artikull shkencor i botuar më 01 shkurt 2009" @default.
- Q83178347 description "artículu científicu espublizáu en febreru de 2009" @default.
- Q83178347 description "bài báo khoa học" @default.
- Q83178347 description "im Februar 2009 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83178347 description "scientific article published on 01 February 2009" @default.
- Q83178347 description "wetenschappelijk artikel" @default.
- Q83178347 description "наукова стаття, опублікована в лютому 2009" @default.
- Q83178347 name "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 name "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 name "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 type Item @default.
- Q83178347 label "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 label "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 label "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 prefLabel "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 prefLabel "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 prefLabel "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 P1433 Q83178347-AEB72026-1D51-4E4C-98C2-20E3010BE350 @default.
- Q83178347 P1476 Q83178347-C871DBC9-8F3E-4A1F-A44D-5CAE5B2F635A @default.
- Q83178347 P2093 Q83178347-2E10F863-EC0F-4A03-A671-6FE2B9BB188C @default.
- Q83178347 P2093 Q83178347-9FA155BF-BA4D-4550-80F2-0D6C3D7CFE7A @default.
- Q83178347 P2093 Q83178347-A97A237A-C3B4-440E-A355-CA3F5F9A044E @default.
- Q83178347 P2093 Q83178347-A9F8F90E-05B4-407D-B2D1-A736DE132FBF @default.
- Q83178347 P304 Q83178347-6CC44199-FBC0-41D9-B7B0-D232F4CD1693 @default.
- Q83178347 P31 Q83178347-F04A1556-649B-4899-800F-26F180ABB136 @default.
- Q83178347 P356 Q83178347-65C76930-45B6-4D38-81EF-A2499418272C @default.
- Q83178347 P433 Q83178347-41DA661C-B3A0-4ADE-A9E5-F9563BFECB5E @default.
- Q83178347 P478 Q83178347-D6FFFD60-A2D8-4A42-9BDA-6173B7A26D3C @default.
- Q83178347 P50 Q83178347-9BD0FF24-0B45-4E7E-930E-25BCFE054030 @default.
- Q83178347 P577 Q83178347-0AA53AC3-31C8-475F-9699-B62D657A6AD2 @default.
- Q83178347 P698 Q83178347-8755FD52-1FAB-404C-BCF4-9D884B883760 @default.
- Q83178347 P921 Q83178347-17B26CA5-892A-4C83-A739-67D64B8B06E5 @default.
- Q83178347 P356 ARD.2008.092601 @default.
- Q83178347 P698 19139205 @default.
- Q83178347 P1433 Q4767876 @default.
- Q83178347 P1476 "Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment" @default.
- Q83178347 P2093 "A Vissink" @default.
- Q83178347 P2093 "H Bootsma" @default.
- Q83178347 P2093 "J M Meijer" @default.
- Q83178347 P2093 "J Pijpe" @default.
- Q83178347 P304 "284-285" @default.
- Q83178347 P31 Q13442814 @default.
- Q83178347 P356 "10.1136/ARD.2008.092601" @default.
- Q83178347 P433 "2" @default.
- Q83178347 P478 "68" @default.
- Q83178347 P50 Q87375577 @default.
- Q83178347 P577 "2009-02-01T00:00:00Z" @default.
- Q83178347 P698 "19139205" @default.
- Q83178347 P921 Q412323 @default.